Skip to main content
. 2018 Sep 26;10:3973–3981. doi: 10.2147/CMAR.S172940

Table 2.

Cox regression analysis of mortality risk for all patients

Variable Univariate analysis (n =70)
Multivariate analysis (n =70)
HR P-value 95% CI aHR P-value 95% CI
Group
 Group A (Ref.) 1.00 1.00
 Group B 2.94 0.009 (1.32–6.57) 3.73 0.011 (1.36–10.25)
 Group C 1.17 0.737 (0.47–2.91) 1.67 0.356 (0.57–4.86)
Sex
 Male (Ref.) 1.00 1.00
 Female 0.86 0.685 (0.42–1.76) 0.64 0.299 (0.27–1.50)
Age (years)
 ≤60 (Ref.) 1.00 1.00
 >60 1.00 0.997 (0.45–2.23) 1.09 0.866 (0.40–2.95)
Stage
 Stage I (Ref.) 1.00 1.00
 Stage II 1.28 0.657 (0.43–3.82) 1.56 0.510 (0.42–5.84)
 Stage III 1.67 0.334 (0.59–4.70) 1.91 0.272 (0.60–6.06)
 Stage IVA 5.56 0.001 (2.01–15.40) 7.73 0.002 (2.17–27.51)
CEA (ng/mL)
 ≤5.0 (Ref.) 1.00 1.00
 >5.0 3.08 0.016 (1.23–7.71) 1.874 0.252 (0.64–5.49)

Notes: All variables were used in multivariate analysis. Group A, narrow-margin hepatectomy plus postoperative radiotherapy; Group B, narrow-margin hepatectomy alone; Group C, wide-margin hepatectomy alone.

Abbreviations: aHR, adjusted hazard ratio; HR, hazard ratio; CI, confidence interval; CEA, carcinoembryonic antigen; Ref, reference group.